The FDA Is Fast-Tracking a Second Psilocybin (Aka Shrooms) Drug to Treat Depression

If you’ve ever struggled with depression, then you know how difficult it is to find the right medication and the right dosage. People often spend months trying to find the right combination that works for them because no two people are the same, and doctors need to adjust.

Well, there might be some pretty good news on that front coming soon in the form of an unexpected source.

The FDA has given the hallucinogenic compound psilocybin a “Breakthrough Therapy” designation for the second time in just over a year. Psilocybin is the compound that gives “magic mushrooms” their hallucinogenic powers.

Magic mushrooms

The Breakthrough Therapy designation is meant to expedite drugs for development and review by the FDA. Furthermore, the designation is only given to drugs and therapies that have been shown to be effective in treating medical conditions in the preliminary phases.

Last year the FDA granted a Breakthrough Therapy designation to a company called Compass Pathways for using psilocybin to help with treatment-resistant depression. This type of depression has been shown to not improve with two or more traditional therapies. Also, earlier this year, the FDA approved a nasal spray for treatment-resistant depression that is intended to mimic the positive effects of the hallucinogenic drug ketamine. Remarkably, his was the first new antidepressant approved by the FDA in decades.

Depression

The difference with the new Breakthrough Therapy designated drug is that this time it is focused on major depressive disorder, which affects at least 17 million adults in America. The new research will go through the Usona Institute in Madison, Wisconsin, where trials will study how depressed patients do after being treated with one dose of psilocybin.

Most likely, it will be several years before any products related to this study would potentially hit the market.

Depressed

Still, this is good news for the millions of people out there struggling with depression.

Are hallucinogens the wave of the future? Seems like the 60s all over again…

What do you think about potentially using hallucinogenic drugs to treat cases of depression? Let us know your thoughts in the comments.

The post The FDA Is Fast-Tracking a Second Psilocybin (Aka Shrooms) Drug to Treat Depression appeared first on UberFacts.

FDA Warns Parents Not to Let Babies Use Teething Jewelry

As a parent, there’s nothing worse than seeing your little one in pain while you stand by, powerless to stop it. And while cutting teeth is just a painful rite of passage, the popularity of “teething jewelry” at least gave parents the illusion they were doing something to help.

 

View this post on Instagram

 

A post shared by Kendra Raymer Blog (@kendra.raymer) on

But After the strangulation death of an 18-month-old, the Food and Drug Administration is officially cautioning against it.

“We know that teething necklaces and jewelry products have become increasingly popular among parents and caregivers who want to provide relief for children’s teething pain and sensory stimulation for children with special needs. We’re concerned about the risks we’ve observed with these products and want parents to be aware that teething jewelry puts children, including those with special needs, at risk of serious injury.”

And if you’re sitting there thinking you’d never put your baby to bed wearing a necklace, well, you’re not in the clear – a 7-month-old baby died after choking on a teething bracelet while his parents were in the room with him.

 

View this post on Instagram

 

A post shared by Khansa Khadijah Wijaya (@khansakhadijahwijaya) on

“Choking can happen if the jewelry breaks and a small bead enters the child’s throat or airway,” the report continued. “Strangulation can occur if a necklace is wrapped too tightly around the child’s neck or if the necklace catches on an object such as a crib.”

The FDA also reminds parents that they don’t recommend the use of “teething creams, benzocaine gels, sprays, ointments, solutions, or lozenges for mouth and gum pain” either, and suggests following American Academy of Pediatrics’ guidelines for soothing teething pain.

 

View this post on Instagram

 

A post shared by 🧿Mella🧿 (@cbyem) on

Those include rubber teething rings (cold is best!) or rubbing the irritated gums with a clean finger.

It’s hard to watch, parents, and even harder to have patience with a constantly irritated infant, but according to the FDA, the risks of using the jewelry to mitigate everyone’s pain is too much.

My advice? Try a large, peeled carrot right out of the fridge. Works like a charm!

The post FDA Warns Parents Not to Let Babies Use Teething Jewelry appeared first on UberFacts.